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Edited by Jesus AvilaAbstract We used a bovine brain cDNA library to perform a
yeast two-hybrid assay with bovine mature PrPC as bait. The
screening result showed that aB-crystalline interacted with
PrPC. The interaction was further evaluated both in vivo and
in vitro with diﬀerent methods, such as immunoﬂuorescent colo-
calization, native polyacrylamide-gel electrophoresis, and IAsys
biosensor assays. The results suggested that aB-crystalline
may have the ability to refold denatured prion proteins, and pro-
vided ﬁrst evidence that aB-crystalline is directly associated with
prion protein.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transmissible spongiform encephalopathies (TSE) or prion
diseases are an unusual group of fatal neurodegenerative disor-
ders, including bovine spongiform encephalopathy (BSE) in
cattle, scrapie in sheep, and Creutzfeldt–Jacob disease (CJD)
in human. The hallmark of the diseases was an aberrant
metabolism and resulting accumulations of scrapie form of
prion protein (PrPSc), which is rich in b-sheets, partial protease
resistant and converted from the cellular normal prion protein
(PrPC), which is a soluble form with a predominant a-helical
conformation [1]. The molecular mechanism of the conversion
still remains enigmatic. Some studies have suggested that other
protein may inﬂuence TSE pathogenesis or regulate the disease
[2,3], but the protein remain unidentiﬁed.
PrPC is a highly conserved GPI-anchored protein and is
mainly expressed in neurons [4,5]. However, its physiological
function is unclear. Several studies have demonstrated that
PrPC is a copper binding protein, and the copper binding en-
dows PrPC with superoxide dismutase activity [6,7]. Attempts
to gain further insight into the putative function of PrPC have
led to characterization of some related proteins, such as mouseAbbreviations: TSE, transmissible spongiform encephalopathies; BSE,
bovine spongiform encephalopathy; CJD, Creutzfeldt–Jacob disease;
BoPrPC, bovine mature PrPC; sHsp, small heat-shock proteins
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doi:10.1016/j.febslet.2005.08.065STLI [8,9], Synapsin, Grb-2 and Pint 1 [10], N-CAMs [11,12],
Kringle domains [13], immunoglobulin C2 and ﬁbronectin
type III-like motifs [14], Pli45 and Pli110, glial ﬁbrillary acidic
protein [15], which were associated with murine PrPC, and 37-
kDa/67-kDa LRP [16,17] acting as a human PrPC receptor.
These proteins could interact with PrPC at the cell membrane,
in endocytic compartments or in the secretory pathway, sug-
gesting that PrPC might play a role in signal transduction
[9,10] and in neuronal adhesion and neurite growth [11,12].
But till now, none of interrelated proteins in bovine was found.
With the increased cases of BSE outbreaking, great eﬀorts
have been made to explore the disease. In this paper, using a
cDNA library derived from bovine brain as prey, we performed
a yeast two-hybrid assay with bovine mature PrPC (BoPrPC) as
bait. The results showed that BoPrPC associated with aB-crys-
talline. aB-crystalline is a member of the small heat-shock pro-
teins (sHsp) family of molecular chaperones. sHsps generally
have the ability to refold stressed proteins [18,19]. Our results
revealed that BoPrPC can directly interact with aB-crystalline.2. Materials and methods
2.1. Yeast two-hybrid screen
2.1.1. Construction of pGBDKT7-PrPC. The gene of mature
BoPrPC (25-242) was ampliﬁed by polymerase chain reaction (PCR)
using bovine genomic DNA as a template and then cloned into
pGBDKT7 (Clontech) vector via NdeI–EcoRI restriction sites, yielding
pGBDKT7-PrPC as bait.
2.1.2. Construction of pGADT7-cDNA. The bovine brain cDNA li-
brary (Uni-ZAP XR Library) was purchased from Stratagene, cDNA
fragments were ligated into pGADT7 (Clontech) with EcoRI–XhoI
sites, resulting in pGADT7-cDNA as prey.
2.1.3. Yeast two-hybrid screen. Saccharomyces cerevisiae strain
PJ69-4A cells were co-transformed with both prey and bait plasmids.
Positive clones were selected on synthetic dropout (SD) medium in
the absence of four nutrients (Leu, Trp, Ade and His). It grew 5–7
days, and was tested for b-galactosidase activity. Colonies turning to
blue were reserved, and the positive results were conﬁrmed by repeat-
ing the assay. Then the pGADT7-cDNA plamids isolated from the po-
sitive clones were co-transformed into yeast with the empty plasmid
pGBDKT7 or the bait plasmid pGBDKT7-PrPC, for the autoactiva-
tion test or the interaction reconﬁrmation, respectively.
The inserted DNA fragments on the positive clones were sequenced
with the T7-sequencing primer. Sequences were performed by Blast
network service at the National Center for Biotechnology Information
(http://www.ncbi.nlm.gov/blast).
2.2. Immunoﬂuorescent colocalization
BHK21 cells were grown in DMEM medium, containing 10% fetal
calf serum. At 75% conﬂuence, cells were co-transfected with 3 lg
pSC6-T7-NEO plasmid (kindly provided by Dr. Billeter) expressingblished by Elsevier B.V. All rights reserved.
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mixture using Lipofectamine 2000 (Invitrogen). Transfection eﬃ-
ciency was evaluated by a green ﬂuorescent protein(GFP) plasmid un-
der the control of T7 promoter. Immunoﬂuorescent staining was
performed 48 h after the cotransfection. PrPC-Myc was recognized
by the anti-Myc-FITC monoclonal antibody (Invitrogen), whereas
crystalline-HA was recognized by the anti-HA-Rhodamine monoclo-
nal antibody (Roche). The ﬂuorescent signals were analyzed by the
Leica TCS-AOBS-SP2-MP laser confocal microscope.
2.3. Protein preparation
The aB-crystalline cDNA was ampliﬁed by PCR using a bovine
brain cDNA library as template, and was inserted into vector pET30a
(Novagen) via EcoRI–XhoI sites, resulting in pET30a-aB-crystalline
plasmid. The method of constructing pET30a-PrPC is the same as that
of pGBDKT7-PrPC as described above. After veriﬁcation by sequenc-
ing, the two constructs of plasmids were transformed into E. coli BL21
(DE3) separately. The on-column puriﬁcation and refolding of
pET30a-PrPC were performed as described previously [21]. The ex-
pressed aB-crystalline was puriﬁed using immobilized metal aﬃnity
chromatography (MAMC) with Ni-NTA His Bind Resins (Novagen)
according to the manufacturers instructions.
The puriﬁed proteins were veriﬁed by SDS–PAGE and the concen-
trations were measured using the Bio-Rad protein assay kit (Bio-Rad)
with bovine serum albumin as a standard according to the manufac-
turers instructions.
2.4. IAsys biosensor measurements
The measurements were performed using an IAsys biosensor (Aﬃn-
ity Sensors, Cambridge, UK). BoPrPC was immobilized on carboxym-
ethyl-dextran cuvette surfaces. Binding assay was performed in 50 mM
sodium phosphate, pH 7.2. aB-crystalline protein was added to a ﬁnal
concentration of 6–192 nM in a total volume of 200 ll, and changes in
resonant angle were monitored at 1 s intervals for approximately 300 s.
The experiments were performed at 25 C with a stirrer speed of
85 rpm. For repeated measurements with diﬀerent concentration of
aB-crystalline using the same cuvette, the surface was regenerated by
washing it two times in 20 mM NaHCO3.
2.5. Native polyacrylamide-gel electrophoresis
The action mixtures of BoPrPC and aB-crystalline protein at indi-
cated concentrations were mixed with glycine native sample loading
buﬀer and were then loaded (25 ll per well) on a glycine precast gel
(7.5%). Gel electrophoresis was carried out with constant 150 V at
4 C for 1.5 h.The gel was then stained with Coomassie blue.
2.6. Refold assays of PrP
The BoPrP was unfolded in 8 M Urea, 100 mM sodium phosphate,
10 mM b-mercaptoethanol, 0.5% Triton-100 and 10 mM Tris–HCl
solution at pH 8.0 overnight at 4 C. Aliquots of samples (3 mg/ml)
would be assayed for refolding. The mixture was diluted 100 times with
100 mM sodium phosphate, 10 mM Tris–HCl solution (pH 7.0) con-
taining a diverse concentrations of aB-crystalline (0, 1, 2, 3, 4, 5 lg/ml).Fig. 1. Identiﬁcation of interaction between BoPrPC and aB-crystalline in the
auto-activity was found in pGADT7-aB-crystalline, (B) interaction of BoPr
interact with SV40 large T-antigen, (D) positive control, pCL1 encoded fu
interacted with SV40 large T-antigen.The diluted solutions were centrifuged for 5 min at 12000 · g, the sus-
pensions were concentrated by centrifugal ﬁlter devices (Millipore),
and then analyzed by SDS–PAGE. At the same time, the conformation
of the suspensions was investigated by JASCO J-810 Spectropolarim-
eter. The circular dichroism spectra gave its raw output in ellipticity,
and was measured in millidegrees.3. Result
To ﬁnd proteins physically interacting with the bovine cellu-
lar prion protein, we employed a yeast two-hybrid screening
method. The screening of the library revealed that several yeast
clones had positive signals in the b-galactosidase assay. The
pGADT7-cDNA plasmids isolated from positive clones were
transformed into E. coli for ampliﬁcation. After isolation from
E. coli, the positive pGADT7-cDNA was co-transformed with
pGBKT7 or pGBDKT7-PrPC for the autoactivation test or for
the reconﬁrmation of the interaction. Sequencing of the iso-
lated positive plasmids showed that several of these positive
clones sequences were identical with the bovine aB-crystalline
protein gene sequence. Fig. 1(A) shows that aB-crystalline was
not of auto-activity and Fig. 1(B) shows that aB-crystalline
interacted with BoPrPC by b-galactosidase assay.
To determine whether BoPrPC and aB-crystalline were co-
localized in mammalian cells, pGADT7-aB-crystalline,
pGBDKT7-BoPrPC expression vectors were co-transformed
into BHK21 cells in which the co-transformed pSC6-T7-
NEO plasmid provided T7 polymerase. The expression of
BoPrPC-Myc protein and aB-crystalline-HA protein was mon-
itored by immunoﬂuorescent staining using anti-Myc-FITC
monoclonal antibody and anti-HA-Rhodamine monoclonal
antibody, respectively. Confocal microscope analysis of ﬂuo-
rescent image revealed that BoPrPC and aB-crystalline pro-
teins were co-localizing in mammalian cells (Fig. 2). The bait
plasmid that encoded the mature form of BoPrPC that was
located in the cytosol, so BoPrPC and aB-crystalline were
co-localized in the cytosol.
Native polyacrylamide-gel electrophoresis (N-PAGE) and
IAsys biosensor assays were employed to detect the association
of the two proteins in vitro. In the N-PAGE (Fig. 3), BoPrPC,
with net positive charges, migrated up and oﬀ the gel, so no
band could be detected in the gel; whereas aB-crystalline mi-
grated down in the gel, for its net negative charge. The mixture
of BoPrPC and aB-crystalline showed two bands. The upper
band had the same position as isolated aB-crystalline, andyeast two-hybrid system by assaying b-galactosidase activities. (A) No
PC with aB-crystalline, (C) negative control, human lamin C did not
ll-length, wild-type GAL4 protein, (E) positive control, murine P53
Fig. 2. BoPrPC co-localized with aB-crystalline in BHK21 cells. (A) Texas red immunoﬂuorescent staining of aB-crystalline-HA fusion protein by
monoclonal antibody recognizing HA sequence; (B) FITC immunoﬂuorescent staining of BoPrPC-Myc fusion protein by monoclonal antibody
recognizing the Myc sequence; (C) overlay of FITC and Texas red immunoﬂuorescent staining detected by laser confocal microscope.
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association of BoPrPC and aB-crystalline (Fig. 3A). In
Fig. 3B, the concentrations of BoPrPCare constant, the inten-Fig. 3. The associations of BoPrPC with aB-crystalline were deter-
mined by N-PAGE. (A) Lane 1, only loaded aB-crystalline with net
negative charge. Lane 2, the reaction complex of BoPrPC and aB-
crystalline showed two bands. The upper band had the same position
as isolated aB-crystalline, and the lower one was expected to be the
complex of BoPrPC and aB-crystalline. Lane 3, BoPrPC, carrying net
positive charges, showed no band. (B) With increasing concentrations
of aB-crystalline (from lane 2 to lane 6: 0, 30, 60, 90, 120 lM), the
intensity of the complex bands increased, while BoPrPC is at a constant
concentration (120 M).sity of the mixture bands increased with increasing concentra-
tions of aB-crystalline (from lane 2 to lane 6). These data
showed that formation of the complex depended on the con-
centration of aB-crystalline.
The IAsys biosensor was used to analyze the interaction be-
tween the two proteins in real time in vitro. Binding curves are
shown in Fig. 4A and indicate the speciﬁc binding of the aB-
crystalline to immobilized BoPrPC. The association (kass) and
dissociation constant (kdiss) values were calculated based on
the Kon value for diﬀerent concentration of aB-crystalline at
6, 12, 24, 48, 96 and 192 nM using the IAsys Fit program algo-
rithm. The kass and kdiss were 671762.65681 M
1 S1 and
0.26703 S1, respectively. From the ratio of the respective rate
constants, KD = 3.98e  7 M was determined, the data sug-
gested their binding was high aﬃnity. We also noticed that
in Fig. 4(A), the binding curves with 192, 96 and 48 nM dif-
fered from those obtained at 24, 12 and 6 nM due to the spon-
taneous conformation changes in PrPC under the measuring
and regeneration conditions. This accorded with the descrip-
tion of Leclerc et al. [22] that under physiological solvent con-
ditions, monomeric PrPC on the sensor chip surface was an
intrinsically unstable molecule prone to conformational rear-
rangement.
Fig. 4B ﬁtted the biphasic binding of the IAsys Fit pro-
gram algorithm, which indicated that BoPrPC had multiple
binding sites of aB-crystalline. The ﬁrst association, when
BoPrPC was recognized by aB-crystalline, was very fast. Fol-
lowing that process, the BoPrPC might have also explored the
second association site, which was consistent with the Stoc-
kels hypothesis [23] that some factor that aﬀected PrP con-
version would have multiple binding sites allowing
interactions with both the N-terminal segment and the core
domain of PrP.
These ﬁndings conﬁrmed that PrPC could speciﬁcally inter-
act with aB-crystalline both in vivo and in vitro.
As a molecular chaperone, aB-crystalline can capture
chemically denatured model substrates and prevent their pre-
cipitation in a sense [18]. Here, we were interested in whether
aB-crystalline had the ability to refold denatured BoPrP. At
room temperature, BoPrP was unfolded in 8 M urea and did
not signiﬁcantly refold to a soluble state when diluted into a
solution containing 100 mM sodium phosphate, 10 mM Tris–
HCl, and pH 7.0. However, when urea-unfolded BoPrP was
diluted in the same solution containing diﬀerent concentration
of aB-crystalline, as Fig. 5A shows, with an increase amount of
Fig. 4. BoPrPC-aB-crystalline interaction dynamics was analyzed by
an IAsys biosensor. BoPrPC was immobilized on a carboxylate cuvette.
(A) Various concentrations of aB-crystalline were injected into the
cuvette equilibrated with a running buﬀer (50 mM sodium phosphate,
pH 7.2), and signals representing the binding of two proteins were
monitored. The surface was regenerated with 20 mMNaHCO3 and the
binding determination was repeated. (B) Fit of the biphasic binding of
the IAsys Fit program algorithm.
Fig. 5. (A) Refold assays of BoPrP with the help of aB-crystalline.
Denatured BoPrP was diluted from 8 M urea into the dilution buﬀer
(100 mM sodium phosphate, 10 mM Tris–HCl, and pH 7.0) containing
diﬀerent concentration of aB-crystalline (0, 1, 2, 3, 4, 5 lg/ml), and the
refolded BoPrP presenting in suspension were analyzed by SDS–
PAGE. (B) Conformation assays of refold BoPrP by circular dichro-
ism spectra. (The concentrations of each measure samples were 0.3 mg/
ml.) Curve 1: BoPrP in 8 M urea was fully unfolded. Curve 2: aB-
crystalline in the dilution buﬀer showed one negative maximum at
216 nm, representing typical b-sheet. Curve 3: BoPrPC puriﬁed in
MAMC and refolded on-column showed a negative maximum at
208 nm and a shoulder at 222 nm, indicating BoPrPC contained a-helix
structure. Curve 4: With the help of aB-crystalline, the refolded BoPrP
presenting in suspension showed a negative maximum at 208 nm and a
shoulder at 222 nm, similar to curve 3.
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sions also increased. And the far-UV CD spectrum of refolded
soluble BoPrP displayed a negative maximum at 208 nm and a
shoulder at 222 nm (Fig. 5B), suggesting the presence of a sig-
niﬁcant amount of a-helix. It implied that aB-crystalline could
refold denatured BoPrP.4. Discussion
It is the ﬁrst time that the binding of BoPrPC with aB-crys-
talline was conﬁrmed. aB-Crystalline, which is a member of
the sHsp family of molecular chaperones, can recognize un-
folded or partially denatured proteins by their hydrophobic
surface [18,24], and PrPC diﬀers markedly from most other
globular proteins in that its native state contains a large seg-ment (residues 23–126) that is unstructured in solutions [24–
27] and is readily recognized by chaperons. From above re-
sults, we also could propose that BoPrPC directly binded to
aB-crystalline, their association could not involve additional
factors. Our results also suggested that the association of
BoPrPC and aB-crystalline had multiple binding sites. Our fu-
ture study will be interested in whether aB-crystalline ﬁrstly
recognize the unstructured segment of the BoPrPC by its
hydrophobic surface.
Although, aB-crystalline has little expression outside lens
under normal conditions, it has been found in many addi-
tional tissues under stress situations, such as cardiac, skeletal
muscles and brain [28–32]. aB-Crystalline in the neurons of
the brain appeared to be closely related to various neurolog-
ical diseases, and several researches had already showed the
association of increased levels of aB-crystalline with these dis-
eases, such as Alexanders disease [18], CJD [31], Alzheimers
disease [32], and Parkinsons disease [33]. The signiﬁcant fea-
ture of these diseases is the amyloid aggregation and the or-
dered ﬁbril formation may represent of oﬀ-pathway
amorphous aggregation. sHsps acting as molecular chaper-
ones generally prevent the aggregation of other proteins un-
der conditions of physiological stress [18,34]. And they
exhibited a cytoprotective function, preventing neuronal cell
G. Sun et al. / FEBS Letters 579 (2005) 5419–5424 5423death under various noxious conditions. Rekas et al. [35]
suggested thataB-crystalline redirecteda-synuclein fromaﬁbril-
formation pathway towards an amorphous aggregation path-
way, and reduced the amount of physiologically stable amyloid
deposits. However, Kudva et al. [36] suggested aB-crystalline
prevented in vitro ﬁbril formation of Ab1-42, and enhanced
amyloid neurotoxicity. Whether the association between
BoPrPC and aB-crystalline can prevent the PrP from ﬁbril
and neurotoxicity still remains unknown. Our future study
will focus on this. Our data ﬁrstly conﬁrm aB-crystalline di-
rectly interacts with BoPrPC. It may be a key step for both
the understanding of BSE pathogenesis and the development
of therapeutics.
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